Review article · 2022 · Open access
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Theranostics, 12(3), 1030–1060 · Published 1 January 2022 · DOI 10.7150/thno.64805
In brief
“Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies” is a 2022 review article by Luman Liu and 14 co-authors, published in Theranostics. OpenAlex counts 134 citations as of 21 November 2026, which puts it in the top 1% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Theranostics.
- Citations
- 134
- Most cited in
- 2025 (37)
- Field-weighted impact
- 1.79
- References
- 374
- Authors
- 15
Abstract
Pancreatic tumors are highly desmoplastic and immunosuppressive. Delivery and distribution of drugs within pancreatic tumors are compromised due to intrinsic physical and biochemical stresses that lead to increased interstitial fluid pressure, vascular compression, and hypoxia. Immunotherapy-based approaches, including therapeutic vaccines, immune checkpoint inhibition, CAR-T cell therapy, and adoptive T cell therapies, are challenged by an immunosuppressive tumor microenvironment. Together, extensive fibrosis and immunosuppression present major challenges to developing treatments for pancreatic cancer. In this context, nanoparticles have been extensively studied as delivery platforms and adjuvants for cancer and other disease therapies. Recent advances in nanotechnology have led to the development of multiple nanocarrier-based formulations that not only improve drug delivery but also enhance immunotherapy-based approaches for pancreatic cancer. This review discusses and critically analyzes the novel nanoscale strategies that have been used for drug delivery and immunomodulation to improve treatment efficacy, including newly emerging immunotherapy-based approaches. This review also presents important perspectives on future research directions that will guide the rational design of novel and robust nanoscale platforms to treat pancreatic tumors, particularly with respect to targeted therapies and immunotherapies. These insights will inform the next generation of clinical treatments to help patients manage this debilitating disease and enhance survival rates.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Liu, L., Kshirsagar, P., Gautam, S. K., Gulati, M., Wafa, E. I., Christiansen, J. C., White, B. M., Mallapragada, S. K., Wannemuehler, M. J., Kumar, S., Solheim, J. C., Batra, S. K., Salem, A. K., Narasimhan, B., & Jain, M. (2022). Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics, 12(3), 1030–1060. https://doi.org/10.7150/thno.64805
MLA 9
Liu, Luman, et al. “Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.” Theranostics, vol. 12, no. 3, 2022, pp. 1030–1060. https://doi.org/10.7150/thno.64805.
Chicago
Liu, Luman, Prakash Kshirsagar, Shailendra Kumar Gautam, Mansi Gulati, Emad Ibrahim Wafa, John C. Christiansen, Brianna M. White, et al. 2022. “Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.” Theranostics 12 (3): 1030–1060. https://doi.org/10.7150/thno.64805.
Harvard
Liu, L. et al. (2022) ‘Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies’, Theranostics, 12(3), pp. 1030–1060. doi:10.7150/thno.64805.
IEEE
L. Liu et al., “Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies,” Theranostics, vol. 12, no. 3, pp. 1030–1060, 2022, doi: 10.7150/thno.64805.
BibTeX
@article{liu2022nanocarriers,
title = {{Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies}},
author = {Liu, Luman and Kshirsagar, Prakash and Gautam, Shailendra Kumar and Gulati, Mansi and Wafa, Emad Ibrahim and Christiansen, John C. and White, Brianna M. and Mallapragada, Surya K. and Wannemuehler, Michael J. and Kumar, Sushil and Solheim, Joyce C. and Batra, Surinder K. and Salem, Aliasger K. and Narasimhan, Balaji and Jain, Maneesh},
journal = {Theranostics},
year = {2022},
volume = {12},
number = {3},
pages = {1030--1060},
doi = {10.7150/thno.64805},
url = {https://doi.org/10.7150/thno.64805}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 17 | |
| 2023 | 27 | |
| 2024 | 34 | |
| 2025 | 37 | |
| 2026 | 19 |
Its field-weighted citation impact is 1.79: it has been cited 1.79 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic cancer
- nanocarriers
- drug delivery
- tumor immunosuppression
- tumor microenvironment
- desmoplasia
- tumor hypoxia
- interstitial fluid pressure
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Liu, L., Kshirsagar, P., Gautam, S. K., Gulati, M., Wafa, E. I., Christiansen, J. C., White, B. M., Mallapragada, S. K., Wannemuehler, M. J., Kumar, S., Solheim, J. C., Batra, S. K., Salem, A. K., Narasimhan, B., & Jain, M. (2022). Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics, 12(3), 1030–1060. https://doi.org/10.7150/thno.64805
How many times has this paper been cited?
134 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Theranostics: sign in and open the PDF from this page.
Who wrote this paper?
Luman Liu, Prakash Kshirsagar, Shailendra Kumar Gautam, Mansi Gulati, Emad Ibrahim Wafa, John C. Christiansen, Brianna M. White, Surya K. Mallapragada, Michael J. Wannemuehler, Sushil Kumar, Joyce C. Solheim, Surinder K. Batra and 3 more.
What is the DOI of this paper?
10.7150/thno.64805, permanently at https://doi.org/10.7150/thno.64805. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.